These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 19738428)
1. The apoptosis modulating role of SAP (SLAM associated protein) contributes to the symptomatology of the X linked lymphoproliferative disease. Nagy N; Matskova L; Hellman U; Klein G; Klein E Cell Cycle; 2009 Oct; 8(19):3086-90. PubMed ID: 19738428 [TBL] [Abstract][Full Text] [Related]
2. The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease. Nagy N; Matskova L; Kis LL; Hellman U; Klein G; Klein E Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11966-71. PubMed ID: 19570996 [TBL] [Abstract][Full Text] [Related]
3. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development. Nagy N; Klein E Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127 [TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374 [TBL] [Abstract][Full Text] [Related]
5. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection. Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686 [TBL] [Abstract][Full Text] [Related]
6. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives]. Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052 [TBL] [Abstract][Full Text] [Related]
7. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Schuster V; Kreth HW Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803 [TBL] [Abstract][Full Text] [Related]
9. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic. Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776 [TBL] [Abstract][Full Text] [Related]
10. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992 [TBL] [Abstract][Full Text] [Related]
11. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry. Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288 [TBL] [Abstract][Full Text] [Related]
13. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558 [TBL] [Abstract][Full Text] [Related]
14. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia]. Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391 [No Abstract] [Full Text] [Related]
15. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. Marsh RA; Bleesing JJ; Filipovich AH J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973 [TBL] [Abstract][Full Text] [Related]
16. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. Tangye SG J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526 [TBL] [Abstract][Full Text] [Related]
17. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family. Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741 [TBL] [Abstract][Full Text] [Related]